Welcome to our dedicated page for AVMR news (Ticker: AVMR), a resource for investors and traders seeking the latest updates and insights on AVMR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AVMR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AVMR's position in the market.
AVRA Medical Robotics (OTC: AVMR) is progressing with its acquisition of CardioVentures, Inc., as previously disclosed. CardioVentures controls SSI-India, which has clinical approval for its Mantra 2 surgical robotic system. This system, offering superior functionality and lower costs, is now operational in three hospitals and aims to expand into the US and European markets. The merger will rename the company to SS Innovations International, Inc., focusing on further developing SSI-India. This strategic move aims to bolster AVRA's position in the medical robotics industry.
AVRA Medical Robotics, Inc. (OTC: AVMR) announced it has filed all required reports with the SEC as of November 30, 2022, ensuring its current filing status. The company is advancing towards the merger with CardioVentures, Inc., which holds a controlling interest in Sudhir Srivastava Innovations Pvt. Ltd. (SSI-India). Post-merger, AVRA will be renamed SS Innovations International, Inc. and gain control of SSI's intellectual property. AVRA focuses on developing autonomous medical robotic systems integrating AI and software for enhanced surgical precision.
AVRA Medical Robotics, Inc. (OTC: AVMR) provided an update on November 3, 2022, announcing the filing of an additional patent application for its semi-automated robotic system by patent counsel Locke Lord LLP. This follows their prior response to the US Patent Office regarding an earlier patent application. AVRA focuses on developing a fully autonomous medical robotic system utilizing AI and software, with current efforts aimed at creating a precision guidance system for minimally invasive procedures, specifically in aesthetic skin resurfacing.
AVRA Medical Robotics, Inc. (OTC: AVMR) has appointed Dr. Doga Demirel as Senior Design Scientist. Dr. Demirel, an expert in computer science specializing in surgical applications, joins from Florida Polytechnic University. His work includes Virtual Surgical Design and Medical Simulations. CEO Barry Cohen emphasized the potential for Dr. Demirel's expertise to enhance AVRA's advanced surgical robotic systems. The company is also making efforts to update its SEC filings.
AVRA Medical Robotics, Inc. (OTC Pink: AVMR) announced the appointment of Dr. Onur Toker as Senior Design Engineer, aimed at accelerating the development of their advanced surgical robotic system. Dr. Toker, previously of Florida Poly, specializes in tele-robotics and embedded systems. CEO Barry Cohen emphasized that Dr. Toker's expertise will enhance the company's surgical intelligence software, targeting precision in aesthetic procedures. The company is also working with an independent accounting firm to update its SEC periodic reports.
AVRA Medical Robotics (OTCMKTS: AVMR) released an update letter from CEO Barry Cohen, detailing the company’s resilience amid the COVID-19 pandemic. Notably, AVRA eliminated all external debt by year-end 2020 and continued progress on its Medical Robotic System. The company has launched new preventative healthcare devices aimed at decontaminating air from viruses, including a significant $210,000 investment in automotive air decontamination technology. Looking ahead, AVRA remains well-funded for 2021 and is focused on expanding its medical robotics team and enhancing remote operations utilizing 5G technology.
FAQ
What is the market cap of AVMR (AVMR)?
